Bachiller D, Sánchez L
Dev Biol. 1986 Dec;118(2):379-84. doi: 10.1016/0012-1606(86)90007-2.
Dosage compensation is the process by which the total amount of gene products of X-linked genes is equalized in females (2X;2A) and males (X;2A). The achievement of dosage compensation takes place at the transcriptional level. Mutations have been isolated that impair the dosage compensation process. These mutations are the male-specific lethals msl-1, msl-2, and mle, which have been analyzed in the somatic tissues. Our aim was to know whether these mutations affect the germline. For this purpose, pole cells homozygous for the male-specific lethal mutations were transplanted into wild-type host embryos, and we checked whether the mutant pole cells were capable of forming functional sperm. The results are as follows: the msl-1 and msl-2 genes are not needed in the germline, while the mle gene seems to be required for normal spermatogenesis.
剂量补偿是一个过程,通过这个过程,X连锁基因的基因产物总量在雌性(2X;2A)和雄性(X;2A)中得以均等化。剂量补偿在转录水平上实现。已经分离出了损害剂量补偿过程的突变。这些突变是雄性特异性致死基因msl-1、msl-2和mle,它们已在体细胞组织中进行了分析。我们的目的是了解这些突变是否影响生殖系。为此,将对雄性特异性致死突变纯合的极细胞移植到野生型宿主胚胎中,并且我们检查了突变极细胞是否能够形成功能性精子。结果如下:生殖系中不需要msl-1和msl-2基因,而mle基因似乎是正常精子发生所必需的。